Advertisement
Canada markets open in 1 hour 40 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7314
    +0.0017 (+0.23%)
     
  • CRUDE OIL

    82.96
    +0.15 (+0.18%)
     
  • Bitcoin CAD

    87,467.99
    -3,437.95 (-3.78%)
     
  • CMC Crypto 200

    1,356.53
    -26.05 (-1.88%)
     
  • GOLD FUTURES

    2,341.60
    +3.20 (+0.14%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,477.50
    -187.00 (-1.06%)
     
  • VOLATILITY

    16.30
    +0.33 (+2.07%)
     
  • FTSE

    8,091.41
    +51.03 (+0.63%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6821
    +0.0002 (+0.03%)
     

Blueprint Medicines Inks Deal With Roche Worth Up to $1.7 Billion

Blueprint Medicines Inks Deal With Roche Worth Up to $1.7 Billion

Blueprint Medicines (NASDAQ: BPMC) announced Tuesday that global biopharma giant Roche Holdings (OTC: RHHBY) is paying up to $1.7 billion in upfront cash and potential milestones, plus royalties, to obtain commercial rights to market pralsetinib outside the U.